Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study

Kevin L. Schwartz, Nathaniel Jembere, Michael A. Campitelli, Sarah A. Buchan, Hannah Chung and Jeffrey C. Kwong
August 25, 2016 4 (3) E463-E470; DOI: https://doi.org/10.9778/cmajo.20160009
Kevin L. Schwartz
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel Jembere
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Campitelli
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah A. Buchan
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Chung
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey C. Kwong
Institute for Clinical Evaluative Sciences (Schwartz, Jembere, Campitelli, Chung, Kwong); Institute of Health, Policy, Management, and Evaluation (Schwartz), University of Toronto; Dalla Lana School of Public Health (Buchan, Kwong), University of Toronto; Public Health Ontario (Kwong), Toronto Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Influenza vaccine effectiveness estimates for the 2010/11 season, with 95% confidence intervals, from Kwong and associates (31) before and after adjustment for misclassification bias using the validation results from this study.

Tables

  • Figures
    • View popup
    Table 1: Demographic characteristics of the study population and percentage receiving influenza vaccine within the previous 12 months
    CharacteristicPatients, no. (%)n = 47 301Patients who received vaccine, %n =  18 684
    Canadian Community Health Survey cycle
        2007/0833 840 (71.5)38.9
        2009/1013 461 (28.5)41.1
    Sex
        Female25 904 (54.8)42.4
        Male21 397 (45.2)36.1
    Age group, yr
        12-174071 (8.6)24.8
        18-4920 247 (42.8)23.6
        50-6411 815 (25.0)44.6
        ≥ 6511 168 (23.6)68.4
    Residence*
        Urban37 406 (79.1)39.3
        Rural9802 (20.7)40.4
    Neighbourhood income quintile†
        1 (lowest)9342 (19.7)40.3
        29402 (19.9)39.6
        39467 (20.0)39.5
        49568 (20.2)38.7
        5 (highest)9330 (19.7)39.7
    Has regular doctor
        Yes43 110 (91.1)41.3
        No4191 (8.9)21.7
    Risk factors for serious influenza infections‡
        Hypertension13 826 (29.2)61.7
        Asthma6225 (13.2)44.0
        Diabetes4877 (10.3)63.7
        Cancer2572 (5.4)64.4
        COPD1596 (3.4)70.5
        Congestive heart failure1235 (2.6)74.0
        Myocardial infarction928 (2.0)69.6
        Chronic kidney disease886 (1.9)68.9
        Morbid obesity§866 (1.8)43.7
        Stroke861 (1.8)66.0
        Immunosuppression679 (1.4)74.7
        Pregnancy¶512 (1.1)18.0
        Dementia245 (0.5)64.5
        None of the above25 924 (54.8)27.3

    Note: COPD = chronic obstructive pulmonary disease.

    *Missing data on 95 patients.

    †Missing data on 192 patients.

    ‡May add up to more than 100%; patients may have more than 1 risk factor.

    §Body mass index > 40.

    ¶Date of delivery between Nov. 1 and June 1.

      • View popup
      Table 2: Performance measures of Ontario Health Insurance Plan physician billing claims compared with self-reported influenza vaccination using Canadian Community Health Survey data
      CharacteristicImmunity, no.Sensitivity
      (95% CI)
      Specificity
      (95% CI)
      PPV (95% CI)NPV (95% CI)
      TPFPFNTN
      Total93031218939527 38549.8 (49.0-50.5)95.7 (95.5-96.0)88.4 (87.8-89.0)74.5 (74.0-74.9)
      Canadian Community Health Survey cycle
          2007/0865061023666619 64549.4 (48.5-50.2)95.1 (94.8-95.3)86.4 (85.6-87.2)74.7 (74.1-75.2)
          2009/1027971952729774050.6 (49.3-51.9)97.5 (97.2-97.9)93.5 (92.6-94.4)73.9 (73.1-74.8)
      Age group, yr
          12-1720571803299220.3 (17.9-22.8)97.7 (97.1-98.2)74.3 (69.1-79.4)78.8 (77.5-80.1)
          18-491510275327215 19031.6 (30.3-32.9)98.2 (98.0-98.4)84.6 (82.9-86.3)82.3 (81.7-82.8)
          50-6423192632947628544.0 (42.7-45.4)96.0 (95.5-96.5)89.8 (88.6-91.0)68.1 (67.1-69.0)
          ≥ 6552696092373291868.9 (67.9-70.0)82.7 (81.5-84.0)89.6 (88.9-90.4)55.2 (53.8-56.5)
      Sex
          Female5536708544814 21150.4 (49.5-51.3)95.3 (94.9-95.6)88.7 (87.9-89.4)72.3 (71.7-72.9)
          Male3767510394713 17448.8 (47.7-49.9)96.3 (96.0-96.6)88.1 (87.1-89.0)76.9 (76.3-77.6)
      Residence
          Urban74741016722921 68750.8 (50.0-51.6)95.5 (95.3-95.8)88.0 (87.3-88.7)75.0 (74.5-75.5)
          Rural18122012152563845.7 (44.2-47.3)96.6 (96.1-97.0)90.0 (88.7-91.3)72.4 (71.4-73.4)
      Has a regular doctor (patient age, yr)
          Yes (< 65)3924585643021 50537.9 (37.0-38.8)97.4 (97.1-97.6)87.0 (86.0-88.0)77.0 (76.5-77.5)
          Yes (≥ 65)52056002229263270.0 (69.0-71.1)81.4 (80.1-82.8)89.7 (88.9-90.4)54.1 (52.7-55.5)
          No (< 65)11024592296215.7 (13.0-18.4)99.2 (98.9-99.5)82.1 (75.6-88.6)83.3 (82.1-84.6)
          No (≥ 65)64914428630.8 (24.5-37.0)96.9 (95.0-98.9)87.7 (80.1-95.2)66.5 (62.1-71.0)
      Risk factors for serious influenza infections (age ≥ 65 yr)
          Hypertension40124481589167171.6 (70.4-72.8)78.9 (77.1-80.6)90.0 (89.1-90.8)51.3 (49.5-53.0)
          Asthma6516327024470.7 (67.7-73.6)79.5 (75.0-84.0)91.2 (89.1-93.3)47.5 (43.2-51.8)
          Diabetes1 4015954455471.1 (69.1-73.2)77.7 (74.6-80.8)89.4 (87.8-91.0)50.5 (47.5-53.4)
          Cancer8588134235971.5 (68.9-74.1)81.6 (78.0-85.2)91.4 (89.6-93.2)51.2 (47.5-54.9)
          COPD5865526523468.9 (65.7-72.0)81.0 (76.4-85.5)91.4 (89.3-93.6)46.9 (42.5-51.3)
          Congestive heart failure5715120217873.9 (70.8-77.0)77.7 (72.3-83.1)91.8 (89.6-94.0)46.8 (41.8-51.9)
          Myocardial infarction3293413012071.7 (67.6-75.8)77.9 (71.4-84.5)90.6 (87.6-93.6)48.0 (41.8-54.2)
          Chronic kidney disease3233613411670.7 (66.5-74.9)76.3 (69.6-83.1)90.0 (86.9-93.1)46.4 (40.2-52.6)
          Morbid obesity*67< 6< 304572.0 (62.9-81.2)90.0 (81.7-98.3)93.1 (87.2-98.9)63.4 (52.2-74.6)
          Stroke3343912413772.9 (68.9-77.0)77.8 (71.7-84.0)89.5 (86.4-92.6)52.5 (46.4-58.5)
          Immunosuppression3372513312371.7 (67.6-75.8)83.1 (77.1-89.1)93.1 (90.5-95.7)48.0 (41.9-54.2)
          Dementia10721375974.3 (67.2-81.4)73.8 (64.1-83.4)83.6 (77.2-90.0)61.5 (51.7-71.2)
          No risk factors7339547885660.5 (57.8-63.3)90.0 (88.1-91.9)88.5 (86.4-90.7)64.2 (61.6-66.7)
      Risk factors for serious influenza infections (age < 65 yr)
          Hypertension14601761471299949.8 (48.0-51.6)94.5 (93.7-95.3)89.2 (87.7-90.7)67.1 (65.7-68.5)
          Asthma734871084309240.4 (38.1-42.6)97.3 (96.7-97.8)89.4 (87.3-91.5)74.0 (72.7-75.4)
          Diabetes6497657298353.2 (50.4-56.0)92.8 (91.3-94.4)89.5 (87.3-91.7)63.2 (60.8-65.6)
          Cancer2151924345946.9 (42.4-51.5)96.0 (94.3-97.8)91.9 (88.4-95.4)65.4 (61.9-68.9)
          COPD1522112216155.5 (49.6-61.4)88.5 (83.8-93.1)87.9 (83.0-92.7)56.9 (51.1-62.7)
          Congestive heart failure8111608157.4 (49.3-65.6)88.0 (81.4-94.7)88.0 (81.4-94.7)57.4 (49.3-65.6)
          Myocardial infarction94109311850.3 (43.1-57.4)92.2 (87.5-96.8)90.4 (84.7-96.1)55.9 (49.2-62.6)
          Chronic kidney disease81< 6< 7512052.9 (45.0-60.9)96.8 (93.7-99.9)95.3 (90.9-99.8)62.5 (55.7-69.3)
          Morbid obesity*1442714141150.5 (44.7-56.3)93.8 (91.6-96.1)84.2 (78.7-89.7)74.5 (70.8-78.1)
          Stroke63< 6< 5011357.3 (48.0-66.5)96.6 (93.3-99.9)94.0 (88.4-99.7)70.6 (63.6-77.7)
          Pregnancy†67139356541.9 (34.2-49.5)97.8 (96.5-99.0)83.8 (75.7-91.8)85.9 (83.2-88.5)
          No risk factors1725321420917 44729.1 (27.9-30.2)98.2 (98.0-98.4)84.3 (82.7-85.9)80.6 (80.0-81.1)

      Note: CI = confidence interval, COPD = chronic obstructive pulmonary disease, FN = false negative, FP = false positive, NPV = negative predictive value, PPV = positive predictive value, TN = true negative, TP = true positive.

      *Body mass index > 40.

      †Date of delivery between Nov. 1 and June 1.

        • View popup
        Table 3: Performance measures of Ontario Health Insurance Plan physician billing claims compared with self-reported influenza vaccination using Canadian Community Health Survey data, restricted to patients surveyed between Feb. 1 and Aug. 31
        CharacteristicImmunity, no. Sensitivity
        (95% CI)
        Specificity (95% CI)PPV (95% CI)NPV (95% CI)
        TPFPFNTN
        Total5639408574416 01749.5 (48.6-50.5)97.5 (97.3-97.8)93.2 (92.6-93.9)73.6 (73.0-74.2)
        Canadian Community Health Survey cycle
            2007/083745276383110 41449.4 (48.3-50.6)97.4 (97.1-97.7)93.1 (92.4-93.9)73.1 (72.4-73.8)
            2009/1018941321913560349.8 (48.2-51.3)97.7 (97.3-98.1)93.5 (92.4-94.6)74.5 (73.6-75.5)
        Age group, yr
            12-1712634507174519.9 (16.8-23.0)98.1 (97.5-98.7)78.8 (72.4-85.1)77.5 (75.8-79.2)
            18-499601122025906032.2 (30.5-33.8)98.8 (98.6-99.0)89.6 (87.7-91.4)81.7 (81.0-82.5)
            50-641401831770361044.2 (42.5-45.9)97.8 (97.3-98.2)94.4 (93.2-95.6)67.1 (65.8-68.4)
            ≥ 6531521791442160268.6 (67.3-70.0)89.9 (88.6-91.3)94.6 (93.9-95.4)52.6 (50.9-54.4)
        Sex
            Female33452213320822650.2 (49.0-51.4)97.4 (97.0-97.7)93.8 (93.0-94.6)71.2 (70.4-72.1)
            Male22941872424779148.6 (47.2-50.0)97.7 (97.3-98.0)92.5 (91.4-93.5)76.3 (75.4-77.1)
        Residence
            Urban4485348436012 62850.7 (49.7-51.7)97.3 (97.0-97.6)92.8 (92.1-93.5)74.3 (73.7-75.0)
            Rural11425913763 35745.4 (43.4-47.3)98.3 (97.8-98.7)95.1 (93.9-96.3)70.9 (69.6-72.2)
        Has a regular doctor (patient age, yr)
            Yes (< 65)2424218394112 70538.1 (36.9-39.3)98.3 (98.1-98.5)91.7 (90.7-92.8)76.3 (75.7-77.0)
            Yes (≥ 65)31191761349144169.8 (68.5-71.2)89.1 (87.6-90.6)94.7 (93.9-95.4)51.6 (49.8-53.5)
            No (< 65)6311361171014.9 (11.5-18.2)99.4 (99.0-99.7)85.1 (77.0-93.2)82.6 (80.9-84.2)
            No (≥ 65)33< 6< 9516126.2 (18.5-33.9)98.2 (96.1-100.0)91.7 (82.6-100.0)63.4 (57.5-69.3)
        Risk factors for serious influenza infections (age ≥ 65 yr)
            Hypertension240312197789671.0 (69.6-72.6)88.1 (86.1-90.1)95.2 (94.4-96.0)47.8 (45.6-50.1)
            Asthma3681815913469.8 (65.9-73.7)88.2 (83.0-93.3)95.3 (93.2-97.4)45.7 (40.0-51.4)
            Diabetes8085233229370.9 (68.2-73.5)84.9 (81.2-88.7)94.0 (92.4-95.5)46.9 (43.0-50.8)
            Cancer4941919618671.6 (68.2-75.0)90.7 (86.8-94.7)96.3 (94.7-97.9)48.7 (43.7-53.7)
            COPD3481116412868.0 (63.9-72.0)92.1 (87.6-96.6)96.9 (95.2-98.7)43.8 (38.1-49.5)
            Congestive heart failure345101179474.7 (70.7-78.6)90.4 (84.7-96.1)97.2 (95.5-98.9)44.5 (37.8-51.3)
            Myocardial infarction20412786672.3 (67.1-77.6)84.6 (76.6-92.6)94.4 (91.4-97.5)45.8 (37.7-54.0)
            Chronic kidney disease18710816969.8 (64.3-75.3)87.3 (80.0-94.7)94.9 (91.9-98.0)46.0 (38.0-54.0)
            Morbid obesity*400132675.5 (63.9-87.1)100.0 (100.0-100.0)100.0 (100.0-100.0)66.7 (51.9-81.5)
            Stroke19114797070.7 (65.3-76.2)83.3 (75.4-91.3)93.2 (89.7-96.6)47.0 (39.0-55.0)
            Immunosuppression1947846369.8 (64.4-75.2)90.0 (83.0-97.0)96.5 (94.0-99.0)42.9 (34.9-50.9)
            Dementia5911193175.6 (66.1-85.2)73.8 (60.5-87.1)84.3 (75.8-92.8)62.0 (48.5-75.5)
            No risk factors4153527647360.1 (56.4-63.7)93.1 (90.9-95.3)92.2 (89.7-94.7)63.2 (59.7-66.6)

        Note: CI = confidence interval, COPD = chronic obstructive pulmonary disease, FN = false negative, FP = false positive, NPV = negative predictive value, PPV = positive predictive value, TN = true negative, TP = true positive.

        *Body mass index > 40.

        PreviousNext
        Back to top

        In this issue

        CMAJ Open: 4 (3)
        Vol. 4, Issue 3
        4 Aug 2016
        • Table of Contents
        • Index by author

        Article tools

        Respond to this article
        Print
        Download PDF
        Article Alerts
        To sign up for email alerts or to access your current email alerts, enter your email address below:
        Email Article

        Thank you for your interest in spreading the word on CMAJ Open.

        NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

        Enter multiple addresses on separate lines or separate them with commas.
        Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study
        (Your Name) has sent you a message from CMAJ Open
        (Your Name) thought you would like to see the CMAJ Open web site.
        CAPTCHA
        This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
        Citation Tools
        Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study
        Kevin L. Schwartz, Nathaniel Jembere, Michael A. Campitelli, Sarah A. Buchan, Hannah Chung, Jeffrey C. Kwong
        Aug 2016, 4 (3) E463-E470; DOI: 10.9778/cmajo.20160009

        Citation Manager Formats

        • BibTeX
        • Bookends
        • EasyBib
        • EndNote (tagged)
        • EndNote 8 (xml)
        • Medlars
        • Mendeley
        • Papers
        • RefWorks Tagged
        • Ref Manager
        • RIS
        • Zotero
        Share
        Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study
        Kevin L. Schwartz, Nathaniel Jembere, Michael A. Campitelli, Sarah A. Buchan, Hannah Chung, Jeffrey C. Kwong
        Aug 2016, 4 (3) E463-E470; DOI: 10.9778/cmajo.20160009
        Twitter logo Facebook logo Mendeley logo
        • Tweet Widget
        • Facebook Like

        Related Articles

        • PubMed
        • Google Scholar

        Cited By...

        • Promoting Intensive Transitions for Children and Youth with Medical Complexity from Paediatric to Adult Care: the PITCare study--protocol for a randomised controlled trial
        • SARS-CoV-2, Tdap, and influenza vaccination during pregnancy from 2019 to 2022 in Ontario, Canada: a population-based retrospective cohort study
        • Trends and characteristics of Tdap vaccination during pregnancy in Ontario, Canada: a retrospective cohort study
        • Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study
        • Google Scholar

        Similar Articles

        Collections

        • Clinical
          • Health services research
          • Public Health
            • Vaccination
            • Other public health

        Content

        • Current issue
        • Past issues
        • Collections

        About

        • General Information
        • Staff
        • Editorial Board
        • Advisory Panel
        • Contact Us
        • Reprints
        • Copyright and Permissions
        CMAJ Group

        Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

        All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

        To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

        CMA Civility, Accessibility, Privacy

         

         

        Powered by HighWire